Reviews Ultravist


No reviews yet.

Ultravist Drug Description
ULTRAVIST
(iopromide) Injection, for intravenous or intra-arterial use


WARNING: NOT FOR INTRATHECAL USE
Inadvertent intrathecal administration may cause
death, convulsions, cerebral hemorrhage, coma, paralysis, arachnoiditis, acute renal failure, cardiac arrest, seizures, rhabdomyolysis, hyperthermia, and brain edema. [see CONTRAINDICATIONS.]

DRUG DESCRIPTION
ULTRAVIST (iopromide) Injection is a nonionic, water soluble x-ray contrast agent for intravascular administration. Each bottle is to be used as a Pharmacy Bulk Package for dispensing multiple single dose preparations utilizing a suitable
transfer device. The chemical name for iopromide is N,N'-Bis(2,3-dihydroxypropyl)
–2,4,6–triiodo–5– [(methoxyacetyl)amino] –N-methyl–1,3-benzenedicarboxamide.
Iopromide has a molecular weight of 791.12 (iodine content 48.12%).
Iopromide has the following structural formula:








ULTRAVIST Injection is a nonionic, sterile, clear, colorless to slightly yellow,
odorless, pyrogen-free aqueous solution of iopromide, containing 2.42 mg/mL
tromethamine buffer and 0.1 mg/mL edetate calcium disodium stabilizer. ULTRAVIST
Injection Pharmacy Bulk Package is available in three strengths:

240 mg I/mL provides 498.72 mg/mL iopromide,
300 mg I/mL provides 623.4 mg/mL iopromide,
370 mg I/mL provides 768.86 mg/mL iopromide.

During the manufacture of ULTRAVIST Injection, sodium hydroxide or hydrochloric
acid may be added for pH adjustment. ULTRAVIST Injection has a pH of 7.4 (6.5–8)
at 25± 2°C, is sterilized by autoclaving and contains no preservatives.
The iodine concentrations (mg I/mL) available have the following physicochemical
properties:




Property
ULTRAVIST
INJECTION
ULTRAVIST
INJECTION
ULTRAVIST
INJECTION


240 mg I/mL
300 mg I/mL
370 mg I/mL


Osmolality* (mOsmol/kg water) @ 37°C
483
607
774


Osmolarity* (mOsmol/L) @ 37°C
368
428
496


Viscosity (cP) @ 20°C
4.9
9.2
22


  @ 37°C
2.8
4.9
10


Density (g/mL) @ 20°C
1.262
1.330
1.409


  @ 37°C
1.255
1.322
1.399


*Osmolality was measured by vapor-pressure
osmometry. Osmolarity was calculated from the measured osmolal concentrations.



Solutions of ULTRAVIST Injection 240 mg I/mL, 300 mg I/mL and 370 mg I/mL have
osmolalities from approximately 1.1 to 2.7 times that of plasma (285 mOsmol/kg
water).
Last reviewed on RxList: 7/20/2010




Ultravist Drug Description
ULTRAVIST
(iopromide) Injection, for intravenous or intra-arterial use


WARNING: NOT FOR INTRATHECAL USE
Inadvertent intrathecal administration may cause
death, convulsions, cerebral hemorrhage, coma, paralysis, arachnoiditis, acute renal failure, cardiac arrest, seizures, rhabdomyolysis, hyperthermia, and brain edema. [see CONTRAINDICATIONS.]

DRUG DESCRIPTION
ULTRAVIST (iopromide) Injection is a nonionic, water soluble x-ray contrast agent for intravascular administration. Each bottle is to be used as a Pharmacy Bulk Package for dispensing multiple single dose preparations utilizing a suitable
transfer device. The chemical name for iopromide is N,N'-Bis(2,3-dihydroxypropyl)
–2,4,6–triiodo–5– [(methoxyacetyl)amino] –N-methyl–1,3-benzenedicarboxamide.
Iopromide has a molecular weight of 791.12 (iodine content 48.12%).
Iopromide has the following structural formula:








ULTRAVIST Injection is a nonionic, sterile, clear, colorless to slightly yellow,
odorless, pyrogen-free aqueous solution of iopromide, containing 2.42 mg/mL
tromethamine buffer and 0.1 mg/mL edetate calcium disodium stabilizer. ULTRAVIST
Injection Pharmacy Bulk Package is available in three strengths:

240 mg I/mL provides 498.72 mg/mL iopromide,
300 mg I/mL provides 623.4 mg/mL iopromide,
370 mg I/mL provides 768.86 mg/mL iopromide.

During the manufacture of ULTRAVIST Injection, sodium hydroxide or hydrochloric
acid may be added for pH adjustment. ULTRAVIST Injection has a pH of 7.4 (6.5–8)
at 25± 2°C, is sterilized by autoclaving and contains no preservatives.
The iodine concentrations (mg I/mL) available have the following physicochemical
properties:




Property
ULTRAVIST
INJECTION
ULTRAVIST
INJECTION
ULTRAVIST
INJECTION


240 mg I/mL
300 mg I/mL
370 mg I/mL


Osmolality* (mOsmol/kg water) @ 37°C
483
607
774


Osmolarity* (mOsmol/L) @ 37°C
368
428
496


Viscosity (cP) @ 20°C
4.9
9.2
22


  @ 37°C
2.8
4.9
10


Density (g/mL) @ 20°C
1.262
1.330
1.409


  @ 37°C
1.255
1.322
1.399


*Osmolality was measured by vapor-pressure
osmometry. Osmolarity was calculated from the measured osmolal concentrations.



Solutions of ULTRAVIST Injection 240 mg I/mL, 300 mg I/mL and 370 mg I/mL have
osmolalities from approximately 1.1 to 2.7 times that of plasma (285 mOsmol/kg
water).
Last reviewed on RxList: 7/20/2010




Ultravist Drug Description
ULTRAVIST
(iopromide) Injection, for intravenous or intra-arterial use


WARNING: NOT FOR INTRATHECAL USE
Inadvertent intrathecal administration may cause
death, convulsions, cerebral hemorrhage, coma, paralysis, arachnoiditis, acute renal failure, cardiac arrest, seizures, rhabdomyolysis, hyperthermia, and brain edema. [see CONTRAINDICATIONS.]

DRUG DESCRIPTION
ULTRAVIST (iopromide) Injection is a nonionic, water soluble x-ray contrast agent for intravascular administration. Each bottle is to be used as a Pharmacy Bulk Package for dispensing multiple single dose preparations utilizing a suitable
transfer device. The chemical name for iopromide is N,N'-Bis(2,3-dihydroxypropyl)
–2,4,6–triiodo–5– [(methoxyacetyl)amino] –N-methyl–1,3-benzenedicarboxamide.
Iopromide has a molecular weight of 791.12 (iodine content 48.12%).
Iopromide has the following structural formula:








ULTRAVIST Injection is a nonionic, sterile, clear, colorless to slightly yellow,
odorless, pyrogen-free aqueous solution of iopromide, containing 2.42 mg/mL
tromethamine buffer and 0.1 mg/mL edetate calcium disodium stabilizer. ULTRAVIST
Injection Pharmacy Bulk Package is available in three strengths:

240 mg I/mL provides 498.72 mg/mL iopromide,
300 mg I/mL provides 623.4 mg/mL iopromide,
370 mg I/mL provides 768.86 mg/mL iopromide.

During the manufacture of ULTRAVIST Injection, sodium hydroxide or hydrochloric
acid may be added for pH adjustment. ULTRAVIST Injection has a pH of 7.4 (6.5–8)
at 25± 2°C, is sterilized by autoclaving and contains no preservatives.
The iodine concentrations (mg I/mL) available have the following physicochemical
properties:




Property
ULTRAVIST
INJECTION
ULTRAVIST
INJECTION
ULTRAVIST
INJECTION


240 mg I/mL
300 mg I/mL
370 mg I/mL


Osmolality* (mOsmol/kg water) @ 37°C
483
607
774


Osmolarity* (mOsmol/L) @ 37°C
368
428
496


Viscosity (cP) @ 20°C
4.9
9.2
22


  @ 37°C
2.8
4.9
10


Density (g/mL) @ 20°C
1.262
1.330
1.409


  @ 37°C
1.255
1.322
1.399


*Osmolality was measured by vapor-pressure
osmometry. Osmolarity was calculated from the measured osmolal concentrations.



Solutions of ULTRAVIST Injection 240 mg I/mL, 300 mg I/mL and 370 mg I/mL have
osmolalities from approximately 1.1 to 2.7 times that of plasma (285 mOsmol/kg
water).
Last reviewed on RxList: 7/20/2010




Ultravist Drug Description
ULTRAVIST
(iopromide) Injection, for intravenous or intra-arterial use


WARNING: NOT FOR INTRATHECAL USE
Inadvertent intrathecal administration may cause
death, convulsions, cerebral hemorrhage, coma, paralysis, arachnoiditis, acute renal failure, cardiac arrest, seizures, rhabdomyolysis, hyperthermia, and brain edema. [see CONTRAINDICATIONS.]

DRUG DESCRIPTION
ULTRAVIST (iopromide) Injection is a nonionic, water soluble x-ray contrast agent for intravascular administration. Each bottle is to be used as a Pharmacy Bulk Package for dispensing multiple single dose preparations utilizing a suitable
transfer device. The chemical name for iopromide is N,N'-Bis(2,3-dihydroxypropyl)
–2,4,6–triiodo–5– [(methoxyacetyl)amino] –N-methyl–1,3-benzenedicarboxamide.
Iopromide has a molecular weight of 791.12 (iodine content 48.12%).
Iopromide has the following structural formula:








ULTRAVIST Injection is a nonionic, sterile, clear, colorless to slightly yellow,
odorless, pyrogen-free aqueous solution of iopromide, containing 2.42 mg/mL
tromethamine buffer and 0.1 mg/mL edetate calcium disodium stabilizer. ULTRAVIST
Injection Pharmacy Bulk Package is available in three strengths:

240 mg I/mL provides 498.72 mg/mL iopromide,
300 mg I/mL provides 623.4 mg/mL iopromide,
370 mg I/mL provides 768.86 mg/mL iopromide.

During the manufacture of ULTRAVIST Injection, sodium hydroxide or hydrochloric
acid may be added for pH adjustment. ULTRAVIST Injection has a pH of 7.4 (6.5–8)
at 25± 2°C, is sterilized by autoclaving and contains no preservatives.
The iodine concentrations (mg I/mL) available have the following physicochemical
properties:




Property
ULTRAVIST
INJECTION
ULTRAVIST
INJECTION
ULTRAVIST
INJECTION


240 mg I/mL
300 mg I/mL
370 mg I/mL


Osmolality* (mOsmol/kg water) @ 37°C
483
607
774


Osmolarity* (mOsmol/L) @ 37°C
368
428
496


Viscosity (cP) @ 20°C
4.9
9.2
22


  @ 37°C
2.8
4.9
10


Density (g/mL) @ 20°C
1.262
1.330
1.409


  @ 37°C
1.255
1.322
1.399


*Osmolality was measured by vapor-pressure
osmometry. Osmolarity was calculated from the measured osmolal concentrations.



Solutions of ULTRAVIST Injection 240 mg I/mL, 300 mg I/mL and 370 mg I/mL have
osmolalities from approximately 1.1 to 2.7 times that of plasma (285 mOsmol/kg
water).
Last reviewed on RxList: 7/20/2010




Ultravist Drug Description
ULTRAVIST
(iopromide) Injection, for intravenous or intra-arterial use


WARNING: NOT FOR INTRATHECAL USE
Inadvertent intrathecal administration may cause
death, convulsions, cerebral hemorrhage, coma, paralysis, arachnoiditis, acute renal failure, cardiac arrest, seizures, rhabdomyolysis, hyperthermia, and brain edema. [see CONTRAINDICATIONS.]

DRUG DESCRIPTION
ULTRAVIST (iopromide) Injection is a nonionic, water soluble x-ray contrast agent for intravascular administration. Each bottle is to be used as a Pharmacy Bulk Package for dispensing multiple single dose preparations utilizing a suitable
transfer device. The chemical name for iopromide is N,N'-Bis(2,3-dihydroxypropyl)
–2,4,6–triiodo–5– [(methoxyacetyl)amino] –N-methyl–1,3-benzenedicarboxamide.
Iopromide has a molecular weight of 791.12 (iodine content 48.12%).
Iopromide has the following structural formula:








ULTRAVIST Injection is a nonionic, sterile, clear, colorless to slightly yellow,
odorless, pyrogen-free aqueous solution of iopromide, containing 2.42 mg/mL
tromethamine buffer and 0.1 mg/mL edetate calcium disodium stabilizer. ULTRAVIST
Injection Pharmacy Bulk Package is available in three strengths:

240 mg I/mL provides 498.72 mg/mL iopromide,
300 mg I/mL provides 623.4 mg/mL iopromide,
370 mg I/mL provides 768.86 mg/mL iopromide.

During the manufacture of ULTRAVIST Injection, sodium hydroxide or hydrochloric
acid may be added for pH adjustment. ULTRAVIST Injection has a pH of 7.4 (6.5–8)
at 25± 2°C, is sterilized by autoclaving and contains no preservatives.
The iodine concentrations (mg I/mL) available have the following physicochemical
properties:




Property
ULTRAVIST
INJECTION
ULTRAVIST
INJECTION
ULTRAVIST
INJECTION


240 mg I/mL
300 mg I/mL
370 mg I/mL


Osmolality* (mOsmol/kg water) @ 37°C
483
607
774


Osmolarity* (mOsmol/L) @ 37°C
368
428
496


Viscosity (cP) @ 20°C
4.9
9.2
22


  @ 37°C
2.8
4.9
10


Density (g/mL) @ 20°C
1.262
1.330
1.409


  @ 37°C
1.255
1.322
1.399


*Osmolality was measured by vapor-pressure
osmometry. Osmolarity was calculated from the measured osmolal concentrations.



Solutions of ULTRAVIST Injection 240 mg I/mL, 300 mg I/mL and 370 mg I/mL have
osmolalities from approximately 1.1 to 2.7 times that of plasma (285 mOsmol/kg
water).
Last reviewed on RxList: 7/20/2010





Other reviews about Ultravist on wordpress

Allergic Reaction to IV Contrast Case
  by jcm9232
Allergic Reaction to Intravenous Contrast Author: V. Dimov, M.D. Reviewer: S. Randhawa, M.D. A 46-year old CF was undergoing a CT scan of the abdomen for investigation of abdominal pain. PMH DM2, […]



Other reviews about Ultravist on web:

Ultravist - A well-tolerated, low osmolality, low viscosity contrast agent that enables ease of administration and rapid iodine delivery rate. Bayer HealthCare Pharmaceuticals - Ultravist® Contrast Agent


Learn about the prescription medication Ultravist (Iopromide Injection), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Ultravist (Iopromide Injection) Drug Information: Uses, Side ...


Accurate, FDA approved Ultravist Injection information for healthcare professionals and patients - brought to you by Drugs.com. Ultravist Injection Official FDA information, side effects and uses.


indications contra-indications dosage side-effects pregnancy overdose identification patient information ultravist ULTRAVIST


ULTRAVIST Injection is contraindicated for intrathecal use. Preparatory dehydration (e.g. prolonged fasting and the administration of a laxative before ULTRAVIST Injection) is ... Bayer HealthCare Pharmaceuticals - Diagnostic Imaging Products


Active Ingredients: insulin aspart; insulin aspart protamine Dose Form Description: suspension Route Description: subcutaneous NovoLog Mix 70/30 Strength Description: 30 units ... Generic NovoLog Mix 70/30,Ultravist,Anafranil,Entaprin,Esimil


HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. WARNING: NOT FOR INTRATHECAL USE


Ultravist 370 Milligrams of Iodine Per Milliliter (mg I/mL): Safety and Efficacy in Computed Tomography of Head and Body Ultravist 370 Milligrams of Iodine Per Milliliter (mg I/mL ...


ULTRAVIST® Berlex Canada : Iopromide : Nonionic Iodinated Radiographic Contrast Medium Action And Clinical Pharmacology: Iopromide is a nonionic iodinated radiographic ... RxMed: Pharmaceutical Information - ULTRAVIST


Find patient medical information for Ultravist Inj on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings. Ultravist Inj : Uses, Side Effects, Interactions, Pictures ...





Featured Reviews

Reviews Fluoxetine Hydrochloride

Sarafem Drug Description SARAFEM® (fluoxetine hydrochloride) WARNING Suicidality and Antidepressant Drugs — Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children,...
Read More  |  Review This
Reviews Aldesleukin

Proleukin Drug Description PROLEUKIN® (aldesleukin) For Injection WARNINGS Therapy with PROLEUKIN® (aldesleukin) for injection should be restricted to patients with normal cardiac and pulmonary functions as defined by thallium...
Read More  |  Review This
Reviews Hepatitis B Vaccine

Recombivax Drug Description RECOMBIVAX HB® Hepatitis B Vaccine (Recombinant) DRUG DESCRIPTION What are the possible side effects of this vaccine (Engerix-B, Engerix-B Pediatric, Recombivax HB Adult, Recombivax HB Dialysis Formulation,...
Read More  |  Review This
Reviews Menest

Menest Drug Description Menest® (esterified estrogens) Tablets, USP ESTROGENS INCREASE THE RISK OF ENDOMETRIAL CANCER Close clinical surveillance of all women taking estrogens is important.Adequate diagnostic measures,including...
Read More  |  Review This
Reviews Ethionamide Tablets

Trecator Drug Description Trecator® (ethionamide, USP) Tablets DRUG DESCRIPTION What are the possible side effects of ethionamide (Trecator-SC)? If you experience any of the following serious side effects, stop taking ethionamide...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....